Details for New Drug Application (NDA): 021143
✉ Email this page to a colleague
NDA 021143 describes TRIVAGIZOLE 3, which is a drug marketed by Sun Pharma Canada and is included in one NDA. It is available from six suppliers. Additional details are available on the TRIVAGIZOLE 3 profile page.
The generic ingredient in TRIVAGIZOLE 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
The generic ingredient in TRIVAGIZOLE 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 021143
| Tradename: | TRIVAGIZOLE 3 |
| Applicant: | Sun Pharma Canada |
| Ingredient: | clotrimazole |
| Patents: | 0 |
Suppliers and Packaging for NDA: 021143
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRIVAGIZOLE 3 | clotrimazole | CREAM;VAGINAL | 021143 | NDA | Walgreen Company | 0363-2062 | 0363-2062-01 | 1 TUBE, WITH APPLICATOR in 1 CARTON (0363-2062-01) / 21 g in 1 TUBE, WITH APPLICATOR |
| TRIVAGIZOLE 3 | clotrimazole | CREAM;VAGINAL | 021143 | NDA | AmerisourceBergen | 24385-110 | 24385-110-09 | 1 TUBE, WITH APPLICATOR in 1 CARTON (24385-110-09) / 21 g in 1 TUBE, WITH APPLICATOR |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CREAM;VAGINAL | Strength | 2% | ||||
| Approval Date: | Apr 12, 2000 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
